Aarti Industries fell 2.16% to Rs 1059.30 after consolidated net profit fell 5.5% to Rs 143.50 crore on 18.7% jump in net sales to Rs 1,172.64 crore in Q2 September 2020 over Q2 September 2019.
Consolidated profit before tax (PBT) fell 3.1% to Rs 177.16 crore in Q2 September 2020 as against Rs 182.89 crore in Q2 September 2019. Current tax expense for the quarter slipped 1.1% to Rs 26.62 crore as against Rs 26.92 crore in Q2 September 2019. The Q2 result was declared post market hours yesterday, 10 November 2020.
The board declared an interim dividend of Rs 1.50 (30%) per equity share of Rs 5 each for the FY 2020-21.
Aarti Industries is a manufacturer of specialty chemicals and pharmaceuticals. The company operates through three segments: speciality chemicals, pharmaceuticals, and home & personal care chemicals.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app